poisar

Stocks · News reference

Moderna Advances Ebola Vaccine Into Human Testing

BenzingaAug 5, 2026, 9:47 AMVandana Singh

Moderna starts Phase 1 trials for Ebola vaccine mRNA-1469. See premarket MRNA stock reaction, analyst updates, and ETF exposure.

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
benzinga
Observed
Aug 5, 2026, 9:47 AM
Checked
Aug 5, 2026, 9:47 AM
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading